Organigram Global Inc.
OGI.TO
Get informed when a big investor buys or sells
+ FollowMarket Cap$134.17M
Close$
Share Statistics
| Market cap | $134.17 Million |
|---|---|
| Enterprise Value | $144.29 Million |
| Dividend Yield | $NaN (NaN%) |
| Earnings per Share | $- |
| Beta | - |
| Outstanding Shares | - |
Return
| Return on Equity | 15.61% |
|---|---|
| Return on Assets | 10.59% |
| Return on Invested Capital | -1.35% |
Valuation & Multiples
| P/E Ratio | - |
|---|---|
| PEG | - |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 0.66 |
| Enterprise Value to EBIT | -14.96 |
| Enterprise Value to Net Income | 1 |
| Total Debt to Enterprise | 0.15 |
| Debt to Equity | 0.04 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 11, 2026
EPS Estimate
$-0.01
Average shareholder expectationRevenue Estimate
$96.87 M
Average shareholder expectationNext Earnings Call
Expected Date
December 22, 2026
EPS Estimate
$0.02
Average shareholder expectationRevenue Estimate
$120.65 M
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About OrganiGram Holdings Inc.
1,139 employees
CEO: James Yamanaka Organigram Global Inc. engages in the production and sale of cannabis and cannabis-derived products in Canada. It offers medical cannabis products, including whole flower, milled flower, pre-rolls, infused pre-rolls, vapes, beverages, gu...